Published in Hum Reprod on January 12, 2013
Inositols in the Treatment of Insulin-Mediated Diseases. Int J Endocrinol (2016) 1.40
Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proc Natl Acad Sci U S A (2016) 1.40
Renaming PCOS--a two-state solution. J Clin Endocrinol Metab (2013) 1.08
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol (2014) 1.05
Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol (2016) 0.90
Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates. Endocrinology (2013) 0.90
Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab (2016) 0.90
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89
The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol (2014) 0.88
Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). J Transl Med (2013) 0.88
Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity. PLoS Genet (2015) 0.87
Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance. J Clin Biochem Nutr (2015) 0.87
Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health (2014) 0.85
Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med (2013) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
MicroRNAs in ovarian function and disorders. J Ovarian Res (2015) 0.83
Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study. PLoS One (2015) 0.81
Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab (2014) 0.80
Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise. Biochimie (2014) 0.79
Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab (2015) 0.79
Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep (2015) 0.78
How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study. BMJ Open (2015) 0.78
Acute High-Intensity Interval Exercise-Induced Redox Signaling Is Associated with Enhanced Insulin Sensitivity in Obese Middle-Aged Men. Front Physiol (2016) 0.78
A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice. Biol Reprod (2015) 0.78
Circulating levels and subcutaneous adipose tissue gene expression of pigment epithelium-derived factor in polycystic ovary syndrome and normal women: a case control study. Reprod Biol Endocrinol (2013) 0.78
Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health (2015) 0.77
Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome. Endocrinology (2014) 0.77
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. Int J Endocrinol (2016) 0.77
The feasibility of progressive resistance training in women with polycystic ovary syndrome: a pilot randomized controlled trial. BMC Sports Sci Med Rehabil (2016) 0.77
Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study. PLoS One (2015) 0.77
Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome. J Int Med Res (2017) 0.77
Mental health and physical activity in women with polycystic ovary syndrome: a brief review. Sports Med (2015) 0.76
Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model. Oncol Lett (2015) 0.75
Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome. Physiol Rep (2016) 0.75
Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome. Nutrients (2016) 0.75
Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT. Int J Reprod Biomed (Yazd) (2016) 0.75
The Relationship between Adiposity and Insulin Sensitivity in African Women Living with the Polycystic Ovarian Syndrome: A Clamp Study. Int J Endocrinol (2016) 0.75
To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS. PLoS One (2016) 0.75
An Association Study between INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs in Women with Polycystic Ovary Syndrome from West Azerbaijan Province, Iran. J Reprod Infertil (2015) 0.75
A Single Dose of Prednisolone as a Modulator of Undercarboxylated Osteocalcin and Insulin Sensitivity Post-Exercise in Healthy Young Men: A Study Protocol. JMIR Res Protoc (2016) 0.75
Irregular menstrual cycles in a young woman. CMAJ (2014) 0.75
Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod (2016) 0.75
Polycystic Ovary Syndrome May Be an Autoimmune Disorder. Scientifica (Cairo) (2016) 0.75
Fructose content of low calorie diets: effect on cardiometabolic risk factors in obese women with polycystic ovarian syndrome: a randomized controlled trial. Endocr Connect (2015) 0.75
Acute Low-Volume High-Intensity Interval Exercise and Continuous Moderate-Intensity Exercise Elicit a Similar Improvement in 24-h Glycemic Control in Overweight and Obese Adults. Front Physiol (2017) 0.75
PCOS: Refining diagnostic features in PCOS to optimize health outcomes. Nat Rev Endocrinol (2016) 0.75
Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy. Exp Ther Med (2017) 0.75
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens. Physiology (Bethesda) (2017) 0.75
Weight Management Interventions in Women with and without PCOS: A Systematic Review. Nutrients (2017) 0.75
Identification of reference genes for qRT-PCR in granulosa cells of healthy women and polycystic ovarian syndrome patients. Sci Rep (2017) 0.75
Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol (2011) 1.94
Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause (2009) 1.55
Enhanced cell-surface stability of rescued DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones. Biochem J (2008) 1.49
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.47
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
A systematic review of interventions aimed at the prevention of weight gain in adults. Public Health Nutr (2009) 1.30
Measuring physical activity during pregnancy. Int J Behav Nutr Phys Act (2011) 1.22
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.22
Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring) (2013) 1.15
Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril (2010) 1.12
Weight, physical activity and dietary behavior change in young mothers: short term results of the HeLP-her cluster randomized controlled trial. Nutr J (2009) 1.08
Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.05
Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.04
Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update (2010) 1.03
The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) (2003) 0.99
Preventing weight gain: the baseline weight related behaviors and delivery of a randomized controlled intervention in community based women. BMC Public Health (2009) 0.97
Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC Med Res Methodol (2009) 0.95
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet (2013) 0.92
Polycystic ovary syndrome and weight management. Womens Health (Lond Engl) (2010) 0.92
Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial. Obesity (Silver Spring) (2013) 0.91
The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf) (2012) 0.91
Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt) (2015) 0.90
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care (2008) 0.88
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Fertil Steril (2008) 0.86
The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab (2007) 0.86
Polycystic ovary syndrome - an update. Aust Fam Physician (2012) 0.86
Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern Complement Med (2009) 0.85
Effectiveness and implementation of an obesity prevention intervention: the HeLP-her Rural cluster randomised controlled trial. BMC Public Health (2014) 0.85
Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health (2014) 0.85
The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol (2012) 0.84
Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention. Aust N Z J Obstet Gynaecol (2011) 0.84
Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clin Endocrinol (Oxf) (2014) 0.84
The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology (Carlton) (2008) 0.83
Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis. J Altern Complement Med (2009) 0.83
Status of clomiphene citrate and metformin for infertility in PCOS. Trends Endocrinol Metab (2012) 0.83
How effective is self-weighing in the setting of a lifestyle intervention to reduce gestational weight gain and postpartum weight retention? Aust N Z J Obstet Gynaecol (2014) 0.83
Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2012) 0.82
Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med (2012) 0.82
A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. Clin Sci (Lond) (2009) 0.81
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. Fertil Steril (2011) 0.81
Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause. Menopause (2009) 0.80
Limiting postpartum weight retention through early antenatal intervention: the HeLP-her randomised controlled trial. Int J Behav Nutr Phys Act (2014) 0.80
Vascular function in the diagnostic categories of polycystic ovary syndrome. Hum Reprod (2011) 0.80
Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training. Obesity (Silver Spring) (2012) 0.80
Serum selenium status in Graves' disease with and without orbitopathy: a case-control study. Clin Endocrinol (Oxf) (2014) 0.79
Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) (2007) 0.78
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. Hum Reprod Update (2013) 0.78
Screening for glycaemic abnormalities in PCOS: an ongoing controversy. Hum Reprod (2013) 0.77
Mental health and physical activity in women with polycystic ovary syndrome: a brief review. Sports Med (2015) 0.76
Lost and found: improving ascertainment of refugee-background Australians in population datasets. Comment. Med J Aust (2013) 0.75
The INSPIRED study: a randomised controlled trial of the Whole Person Model of disease self-management for people with type 2 diabetes. BMC Public Health (2014) 0.75
Response to 'insulin sensitivity and leptin in women with Polycystic Ovary Syndrome (PCOS)'. Clin Endocrinol (Oxf) (2015) 0.75
Polycystic ovary syndrome and abnormal glucose tolerance. Med J Aust (2007) 0.75
High incidence of hypoglycemia from an audit of glycemic control and management in patients with diabetes in a cardiac unit. Front Endocrinol (Lausanne) (2013) 0.75
Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome. Med J Aust (2007) 0.75
Alcohol taxation policy in Australia: public health imperatives for action. Comment. Med J Aust (2009) 0.75
Assessing self-efficacy and self-help methods in women with and without Polycystic Ovary Syndrome. Behav Med (2013) 0.75
Health-related behaviors in women with lifestyle-related diseases. Behav Med (2012) 0.75
Erratum: Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: A randomized controlled trial. Obesity (Silver Spring) (2016) 0.75
Metformin in women with PCOS, cons. Endocrine (2014) 0.75
Skin lightening cream: an emerging medical challenge. Med J Aust (2012) 0.75